Skip to main content
SONOSCAPE MEDICAL CORP. logo

SONOSCAPE MEDICAL CORP. — Investor Relations & Filings

Ticker · 300633 ISIN · CNE100002P91 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,204 across all filing types
Latest filing 2026-04-16 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300633

About SONOSCAPE MEDICAL CORP.

https://www.sonoscape.com

SonoScape Medical Corp. specializes in the research, development, and manufacturing of advanced medical diagnostic equipment. The company's primary product portfolio includes high-definition ultrasound systems, flexible endoscopy solutions, and electrocardiography devices. SonoScape focuses on delivering innovative imaging technology to healthcare providers globally, ranging from portable diagnostic tools to comprehensive trolley-based systems. Their ultrasound range covers various clinical applications such as cardiology, obstetrics, and radiology, while their endoscopy division provides high-resolution video processors and scopes for gastrointestinal and respiratory procedures. The company emphasizes continuous technological advancement and clinical efficiency to improve patient outcomes and diagnostic accuracy in diverse medical settings.

Recent filings

Filing Released Lang Actions
关于公司及全资子公司2026年度向银行申请授信额度的公告
Capital/Financing Update Classification · 92% confidence The announcement details the company and its subsidiary’s 2026 bank credit line applications, specifying amounts, banks, and terms. This is an update on the company’s financing activities, not an earnings release, share issuance, or general regulatory filing. It best fits the Capital/Financing Update category (CAP).
2026-04-16 Chinese
2025年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 72% confidence The document is a detailed summary table of non-operating fund occupancies and related-party fund transactions for 2025, required under listing rules. It is not a full Annual Report or Interim/Quarterly Report, nor an earnings release or management discussion. It is a standalone regulatory disclosure of related-party transactions and does not neatly fit into other specific categories. Thus it falls under General Regulatory Filings.
2026-04-16 Chinese
关于使用闲置自有资金进行现金管理的公告
Regulatory Filings Classification · 65% confidence The document is a corporate announcement by Shenzhen Kaili Biomedical Technology Co., Ltd. regarding the Board’s approval to use up to RMB 2 billion of idle self-owned funds for cash management in low-risk financial products (commercial bank products, structured deposits, etc.). It is not an earnings release, annual or interim report, proxy solicitation, management change, share issue, dividend notice, or other more specific category. It clearly serves as a regulatory disclosure of a specific capital usage decision that does not involve new financing or a change in capital structure (so not CAP). Therefore, this announcement falls into the fallback category for miscellaneous regulatory filings (Code: RNS).
2026-04-16 Chinese
长城证券股份有限公司关于公司使用部分闲置募集资金进行现金管理的核查意见
Regulatory Filings Classification · 75% confidence The document is a detailed sponsor’s verification opinion (“核查意见”) regarding the listed company’s use of idle IPO proceeds for cash management, prepared in accordance with listing rules and fundraising supervision regulations. It is not an earnings release, annual or interim financial report, board change notice, dividend notice, audit report, or investor presentation. Rather, it is a regulatory disclosure required for compliance with fundraising oversight rules. No specific category matches “sponsor’s verification opinion,” so it falls under the catch-all “Regulatory Filings” (RNS) classification.
2026-04-16 Chinese
2025 Environmental,Social,and Corporate Governance (ESG)Report
Environmental & Social Information Classification · 95% confidence The document is a comprehensive 2025 Environmental, Social, and Corporate Governance (ESG) Report issued by SonoScape Medical Corp covering environmental, social, and governance performance and metrics for the period Jan 1–Dec 31, 2025. It follows ESG reporting guidelines, details sustainability strategies, stakeholder engagement, and quantitative ESG data. This matches the definition for an ESG report rather than a financial statement, management announcement, or regulatory notice.
2026-04-16 English
2025年度环境、社会及公司治理（ESG）报告
Environmental & Social Information Classification · 95% confidence The document is a standalone annual Environmental, Social, and Governance (ESG) report published by Shenzhen SonoScape. It contains detailed disclosures on sustainability performance, governance structure, social responsibility initiatives, climate actions, stakeholder engagement, and ESG metrics. It is not an annual financial report (10-K), earnings release, board change announcement, or proxy statement, but specifically focuses on environmental and social information. Therefore, it falls under the Environmental & Social Information category (SR).
2026-04-16 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.